– Tatsis Lab –
Evangelos Tatsis
Evangelos Tatsis studies beneficial natural products in plants. Chinese medicinal plants make a vast range of these products, for example the anti-malarial drug artemisin.
He aims to understand and then engineer the metabolic pathways which are responsible for making these natural products in Chinese medicinal plants, thus enabling future health benefits globally.
Evangelos was the first internal candidate to join CEPAMS when he made the move from to Shanghai from the John Innes Centre in 2017.
He is originally from Greece and has also worked at the Max Planck Institute in Germany.
Vast Potential of Natural Products
Plants produce an enormous diversity of beneficial compounds
Metabolic pathways
Understanding exactly how plants produce these products
Genome Enabled Approach
Using bioinformatics, molecular biology, and enzymology techniques, coupled with a plant based synthetic biology platform
CEPAMS Publications
